Advertisement
Review Article| Volume 2, P81-100, September 2020

Update in Imaging of Idiopathic Pulmonary Fibrosis

      Idiopathic pulmonary fibrosis (IPF) is a specific form of progressive, chronic interstitial fibrosis of unknown cause that primarily affects older adults, in the sixth and seventh decades of life, and typically presents as progressive chronic exertional dyspnea.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Clinical Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Thoracic Society; European Respiratory Society
        Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement.
        Am J Respir Crit Care Med. 2000; 161: 646-664
        • King Jr., T.E.
        • Bradford W.Z.
        • Castro-Bernardini S.
        • et al.
        A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
        N Engl J Med. 2014; 370: 2083-2092
        • Richeldi L.
        • du Bois R.M.
        • Raghu G.
        • et al.
        Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
        N Engl J Med. 2014; 370: 2071-2082
        • Raghu G.
        • Collard H.R.
        • Egan J.J.
        • et al.
        An official ATS/ERS/JRS/ALAT statement. Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
        Am J Respir Crit Care Med. 2011; 183: 788-824
        • Raghu G.
        • Chen S.Y.
        • Yeh W.S.
        • et al.
        Idiopathic pulmonary fibrosis in US medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
        Lancet Respir Med. 2014; 2: 566-572
        • Lynch D.A.
        • et al.
        Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
        Lancet Respir Med. 2018; 6: 138-153
        • Wang Y.
        • Kuan P.J.
        • Xing C.
        • et al.
        Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.
        Am J Hum Genet. 2009; 84: 52-59
        • Armanios M.Y.
        • Chen J.J.
        • Cogan J.D.
        • et al.
        Telomerase mutations in families with idiopathic pulmonary fibrosis.
        N Engl J Med. 2007; 356: 1317-1326
        • King Jr., T.E.
        • Tooze J.A.
        • Schwarz M.I.
        • et al.
        Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.
        Am J Respir Crit Care Med. 2001; 164: 1171-1181
        • Guenther A.
        • Krauss E.
        • Tello S.
        • et al.
        The European IPF registry: baseline characterisitics and survival of patients with idiopathic pulmonary fibrosis.
        Respir Res. 2018; 19: 141
        • Kim H.J.
        • Perlman D.
        • Tomic R.
        Natural history of idiopathic pulmomary fibrosis.
        Respir Med. 2015; 109: 661-670
        • Epler G.R.
        Normal chest roentgenograms in chronic diffuse infiltrative lung disease.
        N Engl J Med. 1978; 298: 934-939
        • Thiessen R.D.
        • Fenwick J.L.
        • Lynch D.A.
        Advances in CT diagnosis of UIP and IPF.
        Semin Roentgenol. 2019; 54: 6-14
        • Sverzellati N.
        • Odone A.
        • Silva M.
        • et al.
        • Italian Structured Report in Fibrosing Lung Disease Consort
        Structed reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist.
        Radiol Med. 2018; 123: 245-253
        • Buzan M.T.A.
        • Wetscherek A.
        • Heussel C.P.
        • et al.
        Texture analysis using proton density and T2 relaxation in patients with histological usual interstitial pneumonia (UIP) or nonspecific interstitial pneumonia (NSIP).
        PLoS One. 2017; 12: e0177689
        • Lonzetti L.
        • et al.
        Magnetic resonance imaging of interstitial lung diseases: a state –of-the-art review.
        Respir Med. 2019; 155: 79-85
        • Roos J.E.
        • McAdams H.P.
        • Kaushik S.S.
        • et al.
        Hyperpolarized gas MR imaging: technique and applications.
        Magn Reson Imaging Clin N Am. 2015; 23: 217-229
        • Wang J.M.
        • Robertson S.H.
        • Wang Z.
        • et al.
        Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis.
        Thorax. 2018; 73: 21-28
        • Chan H.F.
        • Weatherly N.D.
        • Johns C.S.
        • et al.
        Airway microstructure in idiopathic pulmonary fibrosis: assessment at hyperpolarized 3He diffusion-weighted MRI.
        Radiology. 2019; 291: 223-229
        • Mammarappallil J.G.
        • Rankine L.
        • Wild J.M.
        • et al.
        New developments in imaging pulmonary fibrosis with hyperpolarized xenon magnetic resonance imaging.
        J Thorac Imaging. 2019; 34: 136-150
        • Manolescu D.
        • Davidescu L.
        • Traila D.
        • et al.
        The reliability of lung ultrasound in assessment of idiopathic pulmonary fibrosis.
        Clin Interv Aging. 2018; 13: 437-444
        • Dietrich C.F.
        • Mathis G.
        • Blaivas M.
        • et al.
        Lung B-line artifacts and their use.
        J Thorac Dis. 2016; 8: 1356-1365
        • Raghu G.
        • et al.
        Diagnosis of idiopathic pulmonary fibrosis. An Official ATS/ERS/JRS/ALAT clinical practice guideline.
        Am J Respir Crit Care Med. 2018; 198: e44-e68
        • Chung J.H.
        • Lynch D.A.
        The value of a multidisciplinary approach to the diagnosis of usual interstitial pneumonitis and idiopathic pulmonary fibrosis: radiology, pathology, and clinical correlation.
        AJR Am J Roentgenol. 2016; 206: 463-471
        • Mohning M.P.
        • Richards J.C.
        • Hui T.J.
        Idiopathic pulmonary fibrosis: the radiologist’s role in making the diagnosis.
        Br J Radiol. 2019; 92: 20181003
        • Kligerman S.
        • et al.
        Nonspecific interstitial pneumonia: radiologic, clinical, and pathologic considerations.
        Radiographics. 2009; 29: 73-87
        • Lee H.Y.
        • Lee K.S.
        • Jeong Y.J.
        • et al.
        High-resolution CT findings in fibrotic idiopathic interstitial pneumonias with little honeycombing: serial changes and prognostic implications.
        AJR Am J Roentgenol. 2012; 199: 982-989
        • Silva C.I.
        • Müller N.L.
        • Lynch D.A.
        • et al.
        Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT.
        Radiology. 2008; 246: 288-297
        • Sahin H.
        • Brown K.K.
        • Curran-Everett D.
        • et al.
        Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival.
        Radiology. 2007; 244: 591-598
        • Criado A.
        • Sanchez M.
        • Ramirez J.
        • et al.
        Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation.
        Radiographics. 2010; 30: 1567-1585
        • Scheeren B.
        • Marchiori E.
        • Pereira J.
        • et al.
        Pulmonary computed tomography findings in patients with chronic aspiration detected by videofluoroscopic swallowing study.
        Br J Radiol. 2016; 89: 20160004
        • Hochhegger B.
        • et al.
        Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics.
        Clinics (Sao Paulo). 2019; 74: e225
        • Simon-Blancal V.
        • Freynet O.
        • Nunes H.
        • et al.
        Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
        Respiration. 2012; 83: 28-35
        • Martinez F.J.
        • Safrin S.
        • Weycker D.
        • et al.
        • IPF Study Group
        The clinical course of patients with idiopathic pulmonary fibrosis.
        Ann Intern Med. 2005; 142: 963-967
        • Akira M.
        • et al.
        Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
        Am J Respir Crit Care Med. 2008; 178: 372-378
        • Collard H.R.
        • Ryerson C.J.
        • Corte T.J.
        • et al.
        Acute exacerbation of idiopathic pulmonary fibrosis: an international working group report.
        Am J Respir Crit Care Med. 2016; 194: 265-275
        • Cottin V.
        • Nunes H.
        • Brillet P.Y.
        • et al.
        Combined pulmonary fibrosis and emphysema: a distinct under-recognized entity.
        Eur Respir J. 2005; 26: 586-593
        • Ryerson C.J.
        • Hartman T.
        • Elicker B.M.
        • et al.
        Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.
        Chest. 2013; 144: 234-240
        • Ozawa Y.
        • Suda T.
        • Naito T.
        • et al.
        Cumulative incidence of and predictive factors for lung cancer in IPF.
        Respirology. 2009; 14: 723-728
        • Hubbard R.
        • Venn A.
        • Lewis S.
        • et al.
        Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
        Am J Respir Crit Care Med. 2000; 161: 5-8
        • Kishi K.
        • Homma S.
        • Kurosaki A.
        • et al.
        High-resolution computed tomography findings of lung cancer associated with idiopathic pulmonary fibrosis.
        J Comput Assist Tomogr. 2006; 30: 95-99
        • Park J.
        • Kim D.S.
        • Shim T.S.
        • et al.
        Lung cancer in patients with idiopathic pulmonary fibrosis.
        Eur Respir J. 2001; 17: 1216-1219
        • Lettieri C.J.
        • Nathan S.D.
        • Barnett S.D.
        • et al.
        Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.
        Chest. 2006; 129: 746-752
        • Collum S.D.
        • Amione-Guerra J.
        • Cruz-Solbes A.-S.
        • et al.
        Pulmonary hypertension associated with idiopathic pulmonary fibrosis: current and future perspectives.
        Can Respir J. 2017; 2017: 1430350
        • Lloyd C.R.
        • Walsh S.L.F.
        • Hansell D.M.
        High-resolution CT of complications of idiopathic fibrotic lung disease.
        Br J Radiol. 2011; 84: 581-592
        • Chung M.J.
        • Goo J.M.
        • Im J.G.
        Pulmonary tuberculosis in patients with idiopathic pulmonary fibrosis.
        Eur J Radiol. 2004; 52: 175-179
        • Ryerson C.J.
        • et al.
        A standardized diagnostic ontology for fibrotic interstitial lung disease. An International Working Group Perspective.
        Am J Respir Crit Care Med. 2017; 196: 1249-1254
        • Chaudhuri N.
        • et al.
        A review of the multidisciplinary diagnosis of interstitial lung diseases: a retrospective analysis in a single UK specialist centre.
        J Clin Med. 2016; 5 ([pii:E66])
        • Flaherty K.R.
        • et al.
        Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?.
        Am J Respir Crit Care Med. 2007; 175: 1054-1060
        • Flaherty K.R.
        • et al.
        Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?.
        Am J Respir Crit Care Med. 2004; 170: 904-910
        • Jo H.E.
        • et al.
        Clinical impact of the interstitial lung disease multidisciplinary service.
        Respirology. 2016; 21: 1438-1444
        • Walsh S.L.F.
        • et al.
        Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
        Lancet Respir Med. 2016; 4: 557-565
        • Staples C.A.
        • et al.
        Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings.
        Radiology. 1987; 162: 377-381
        • Wells A.U.
        • et al.
        Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
        Am J Respir Crit Care Med. 1997; 155: 1657-1664
        • Xaubet A.
        • et al.
        Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis.
        Am J Respir Crit Care Med. 1998; 158: 431-436
        • Oda K.
        • et al.
        High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis.
        Respir Res. 2014; 15: 10
        • Shin K.M.
        • et al.
        Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study.
        Radiology. 2008; 249: 328-337
        • Sumikawa H.
        • et al.
        Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival.
        Am J Respir Crit Care Med. 2008; 177: 433-439
        • Brownell R.
        • et al.
        The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.
        Thorax. 2017; 72: 424-429
        • Wells A.U.
        • et al.
        Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.
        Am J Respir Crit Care Med. 2003; 167: 962-969
        • Ley B.
        • et al.
        A multidimensional index and staging system for idiopathic pulmonary fibrosis.
        Ann Intern Med. 2012; 156: 684-691
        • Ley B.
        • et al.
        Idiopathic pulmonary fibrosis: CT and risk of death.
        Radiology. 2014; 273: 570-579
        • Flaherty K.R.
        • et al.
        Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia.
        Am J Respir Crit Care Med. 2003; 168: 543-548
        • Latsi P.I.
        • et al.
        Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.
        Am J Respir Crit Care Med. 2003; 168: 531-537
        • Best A.C.
        • et al.
        Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality.
        Radiology. 2008; 246: 935-940
        • Jacob J.
        • et al.
        Automated quantitative computed tomography versus visual computed tomography scoring in idiopathic pulmonary fibrosis: validation against pulmonary function.
        J Thorac Imaging. 2016; 31: 304-311
        • Jacob J.
        • et al.
        Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures.
        Eur Respir J. 2017; 49 ([pii:1601011])
        • Humphries S.M.
        • et al.
        Idiopathic pulmonary fibrosis: data-driven textural analysis of extent of fibrosis at baseline and 15-month follow-up.
        Radiology. 2017; 285: 270-278
        • Moroni C.
        • et al.
        Comparison of spirometric-gated and -ungated HRCT in COPD.
        J Comput Assist Tomogr. 2003; 27: 375-379
        • Meng Q.
        • et al.
        Automatic segmentation of airway tree based on local intensity filter and machine learning technique in 3D chest CT volume.
        Int J Comput Assist Radiol Surg. 2017; 12: 245-261
        • Saito S.
        • et al.
        Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis.
        J Thorac Dis. 2019; 11: S1740-S1754
        • Taniguchi H.
        • Ebina M.
        • Kondoh Y.
        • et al.
        Pirfenidone in idiopathic pulmonary fibrosis.
        Eur Respir J. 2010; 35: 821-829
        • Noble P.W.
        • Albera C.
        • Bradford W.Z.
        • et al.
        Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomized trials.
        Lancet. 2011; 377: 1760-1769
        • Flaherty K.
        • et al.
        Nintedanib in patients with chronic fibrosing interstitial lung diseases.
        N Engl J Med. 2019; 381: 1718-1727